SEQUA — Sequana Medical NV Share Price
0.000.00%
Last trade - 00:00- €43.55m
- €58.49m
- €0.71m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 61.17 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -4053.65% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 0.97 | 0.96 | 0.37 | 0.92 | 0.71 | 0.47 | 14.6 | -7.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sequana Medical NV is a Belgium-based company, which manufactures medical devices. The Company focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.
Directors
- Pierre Chauvineau NEC (56)
- Ian Crosbie CEO (51)
- Kirsten Van Bockstaele CFO (44)
- Dirk Fengels VPR (47)
- Timur Resch VPR (37)
- Martijn Blom OTH (45)
- Gijs Klarenbeek OTH (42)
- Erik Amble NED (69)
- Rudy Dekeyser NED (57)
- Jackie Fielding NID
- Wim Ottevaere NID (65)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 31st, 2018
- Public Since
- February 11th, 2019
- No. of Employees
- 60
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Euronext - Brussels
- Shares in Issue
- 30,243,542
- Address
- Kortrijksesteenweg 1112, GENT, 9052
- Web
- https://www.sequanamedical.com/
- Phone
- +32 92928065
- Auditors
- PricewaterhouseCoopers Bedijfsrevisoren
Upcoming Events for SEQUA
Similar to SEQUA
FAQ
What is the Sequana Medical NV share price?
As of Today at 19:19 UTC, shares in Sequana Medical NV are trading at €1.44. This share price information is delayed by 15 minutes.
How has the Sequana Medical NV share price performed this year?
Shares in Sequana Medical NV last closed at €1.44 and the price had moved by -71.31% over the past 365 days. In terms of relative price strength the Sequana Medical NV share price has underperformed the FTSE Global All Cap Index by -73.07% over the past year.
What are the analyst and broker recommendations for Sequana Medical NV?
The overall consensus recommendation for Sequana Medical NV is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Sequana Medical NV dividend yield?
Sequana Medical NV does not currently pay a dividend.
Does Sequana Medical NV pay a dividend?
Sequana Medical NV does not currently pay a dividend.
When does Sequana Medical NV next pay dividends?
Sequana Medical NV does not currently pay a dividend.
How do I buy Sequana Medical NV shares?
To buy shares in Sequana Medical NV you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sequana Medical NV?
As of the previous close price of €1.44, shares in Sequana Medical NV had a market capitalisation of €43.55m.
Where are Sequana Medical NV shares listed?
Here are the trading details for Sequana Medical NV:
- Country of listing: Belgium
- Exchange: BRU
- Ticker Symbol: SEQUA
What kind of share is Sequana Medical NV?
Based on an overall assessment of its quality, value and momentum Sequana Medical NV is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sequana Medical NV share price forecast for 2024?
The analyst consensus target price for shares in Sequana Medical NV is €6.50. That is 351.39% above the last closing price of €1.44.
Analysts covering Sequana Medical NV currently have a consensus Earnings Per Share (EPS) forecast of -€0.41 for the next financial year.
What is the trend in the Sequana Medical NV share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sequana Medical NV. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -55.26%.
As of the last closing price of €1.44, shares in Sequana Medical NV were trading -51.59% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sequana Medical NV PE Ratio?
The Sequana Medical NV PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €1.44.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sequana Medical NV?
Sequana Medical NV's management team is headed by:
- Pierre Chauvineau - NEC
- Ian Crosbie - CEO
- Kirsten Van Bockstaele - CFO
- Dirk Fengels - VPR
- Timur Resch - VPR
- Martijn Blom - OTH
- Gijs Klarenbeek - OTH
- Erik Amble - NED
- Rudy Dekeyser - NED
- Jackie Fielding - NID
- Wim Ottevaere - NID